What is Item 9 Labs Corp. (INLB) stock price today?

Item 9 Labs Corp. (INLB) is currently trading at $0.00.

What is INLB P/E ratio?

Item 9 Labs Corp.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is INLB return on equity (ROE)?

Item 9 Labs Corp.'s return on equity (ROE) is -47.35%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Item 9 Labs Corp.'s market cap?

Item 9 Labs Corp. has a market capitalization of $70181.

OTC · Drug Manufacturers - Specialty & Generic

Item 9 Labs Corp. (INLB) Stock

$0.00 OTC: INLB Healthcare

Based in the United States, Item 9 Labs Corp. operates as a comprehensive cannabis company, encompassing both vertical integration in cannabis operations and the franchising of dispensaries.

Valuation

Metric	Value
Price	$0.00
Market Cap	$70181
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$-0.33
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-47.35%
ROA	-5.40%
ROCE	-32.87%
Gross Margin	49.79%
Operating Margin	-55.70%
Net Margin	-157.61%
Debt/Equity	0.65
Current Ratio	0.06

Annual Financials (USD)

Metric	2018	2019	2020	2021	2022
Revenue	$1.0M	$5.0M	$8.0M	$22.0M	$22.0M
Operating Profit	$-1.0M	$-4.0M	$-5.0M	$-6.0M	$-23.0M
Net Profit	$-1.0M	$-11.0M	$-12.0M	$-11.0M	$-31.0M
EPS	$-0.23	$-0.17	$-0.20	$-0.14	$-0.33
Op Margin	-50.3%	-88.8%	-65.6%	-25.5%	-106.0%

Balance Sheet (USD)

Metric	2018	2019	2020	2021	2022
Total Assets	$4.0M	$14.0M	$21.0M	$117.0M	$111.0M
Total Liabilities	$1.0M	$7.0M	$13.0M	$31.0M	$49.0M
Cash	$0	$0	$0	$1.0M	$0
Borrowings	$0	$5.0M	$8.0M	$21.0M	$28.0M

Cash Flow (USD)

Metric	2018	2019	2020	2021	2022
Operating Cash Flow	$-1.0M	$-2.0M	$-1.0M	$-6.0M	$-2.0M
Investing Cash Flow	$-1.0M	$-14.0M	$-1.0M	$-6.0M	$-11.0M
Financing Cash Flow	$1.0M	$9.0M	$0	$0	$0
Net Cash Flow	$0	$-1.0M	$0	$1.0M	$-1.0M
Free Cash Flow	$-2.0M	$-9.0M	$-2.0M	$-8.0M	$-8.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-1.22
FCF Yield	-10989.73%
Quick Ratio	0.03
Interest Coverage	-3.60
Return 1Y	—
Return 3Y	—
Return 5Y	—

Ownership

Insiders Held0.00%

Institutions Held0.00%

Institutions Float Held0.00%

Institutional Holder	Shares	Report Date
Main Street Group, Ltd	12,081	2024-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BIOIFBiome Grow Inc.	$0.00	—	-0.01	$56208	0.00%
CBGLCannabis Global Inc.	$0.00	—	-3.40	$56821	0.00%
GREHGreen Rain Energy Holdings Inc.	$0.01	+0.00%	0.28	$109851	0.00%
HENCHero Technologies Inc.	$0.00	—	-0.08	$55269	0.00%
ISOLFIsodiol International Inc.	$0.00	—	0.00	$4914	0.00%

About Item 9 Labs Corp.

Based in the United States, Item 9 Labs Corp. operates as a comprehensive cannabis company, encompassing both vertical integration in cannabis operations and the franchising of dispensaries. The firm produces a wide spectrum of cannabis and related goods, such as raw flower, various concentrates, distillates, and necessary hardware. These cannabis and derived technologies and products are then supplied to consumers in Arizona via licensed retail dispensaries. Complementing its production activities, the company also develops and offers medical and adult-use cannabis dispensary franchises under its distinct Unity Rd brand. The main office for Item 9 Labs Corp. is found in Phoenix, Arizona.

Item 9 Labs Corp. (INLB) stock trades at $0.00 with a market capitalization of $70181. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Item 9 Labs Corp. generates a return on equity (ROE) of -47.35%, return on capital employed of -32.87%, an operating margin of -55.70%, a net profit margin of -157.61%.

Official website: www.item9labscorp.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides